Tag: NASH
Nash Overstreet Performs Live DJ Session at Planet Hollywood Adult Scene...
CANCUN, Mexico, Feb. 16, 2023 (GLOBE NEWSWIRE) -- In a movie-themed experience, singer and lead guitarist for the pop rock group...
Metacrine and Its Partners to Present Data at the EASL International...
SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with...
Terns Pharmaceuticals to Host Conference Call to Discuss Top-line Results from...
FOSTER CITY, Calif., June 13, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical...
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences
WEST CONSHOHOCKEN, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc (NASDAQ: MDGL), a clinical- stage biopharmaceutical company pursuing novel...
NGM Bio to Host Conference Call to Discuss Topline Results from...
SOUTH SAN FRANCISCO, Calif., May 23, 2021 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM) will host a conference call and...
Madrigal Pharmaceuticals to Participate in UBS Global Healthcare Virtual Conference
WEST CONSHOHOCKEN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics...
Hepion Pharmaceuticals Completes Final Patient Recruitment in Phase 2a ‘AMBITION’ Clinical...
EDISON, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development...
Hepion Pharmaceuticals Presents Machine Learning “Learn and Confirm” Modeling Strategy at...
EDISON, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on Artificial...
Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Research Showing...
NORCROSS, Ga., April 13, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins,...
Terns Announces Initiation of Dosing in Phase 1 Clinical Trial of...
-TERN-501 is designed to have high metabolic stability, enhanced liver distribution and high selectivity for THR-β- -Top-line data expected in the second...